healthPost Magazine
Chinese stem cell therapy restores heart function in 90% of trial patients - South China Morning Post
Thursday, August 20, 2026
Study finds patients injected with iPSC-derived heart muscle cells outperform control group on cardiac function tests after bypass surgery.
A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy. On Wedne…
This is a summary. Read the full article from the original source:
Read full article →